Table of Contents Table of Contents
Previous Page  276 / 398 Next Page
Information
Show Menu
Previous Page 276 / 398 Next Page
Page Background

271

surgery. Group II also showed significantly lower primary stabil-

ity (

P

< 0.001), but no statistical difference in secondary stability

when compared with the other groups. More smokers were in

Group III (

P

< 0.001), but no relations with MBL, survival rate

and primary/secondary stabilities were found.

Conclusion:

MBL and frequency of sinus membrane perforation

were highest in the Group II, and its survival rate was significantly

lower than the other groups. Early diagnosis and treatment of max-

illary sinusitis before or after the graft and implantation showed

better clinical outcome of dental implants.

http://dx.doi.org/10.1016/j.ijom.2017.02.912

Evaluation of efficacy of demineralised dentin matrix fixed

with recombinant human bone morphogenetic protein-2

S.Y. Kim

∗

, Y.K. Kim, J.C. Park, J.K. Ku, P.Y. Yun

Department of Oral and Maxillofacial Surgery, Seoul National

University Bundang Hospital, Seongnam, South Korea

Objectives:

To evaluate the efficacy of demineralised dentin

matrix (DDM) fixed with recombinant human bone morpho-

genetic protein-2 (rhBMP-2) through experimental and clinical

study.

Methods:

Experimental study: unilateral upper second and third

premolars of eight beagles were extracted. The mucoperiosteal

flap was elevated around extraction socket and bone defect was

formed by surgical drill. Each DDM fixed with rhBMP-2 and

autogenous bone were grafted at bone defect area with collagenous

membrane. Beagles were sacrificed at 2, 4, 8, 12 weeks after bone

graft. Block specimens involving grafted bone and surrounding

nature bone were extracted.

Clinical Study:

A total of 23 patients who received bone graft

using human DDM fixed with rhBMP-2 (AutoBT BMP) with

implant placements (36 implants; maxilla: 14, mandible: 22) were

selected. The implant stability, marginal bone loss and clinical

outcome were evaluated.

Findings:

In the histological evaluation, four weeks after bone

graft, autogenous bone showed 41% of new bone formation and

DDM fixed with rhBMP-2 showed 5% of new bone formation.

Eight weeks after bone graft, autogenous bone showed 46%of new

bone formation andDDMfixedwith rhBMP-2 showed 13%of new

bone formation. At periapical radiograph, both groups showed

newly formed bone which was continuously connected with the

original bone. Favourable osseointegration was obtained in 35 out

of 36 implant sites (one osseointegration failure). In all cases,

severe complications were not observed.

Conclusion:

DDM fixed with rhBMP-2 (AutoBT BMP) provided

good osteoinductive and osteoconductive potentials and clinical

efficacy.

http://dx.doi.org/10.1016/j.ijom.2017.02.913

Facial pain after dental implant installation on maxilla

H.K. Lim

∗

, S.H. Byun, S.M. Kim, M.J. Kim, J.H. Lee

Korea University Guro Hospital, Seoul, South Korea

Background:

There are many reports about traumatic neuralgia

and paraesthesia after injury of inferior alveolar nerve in mandible

due to implants. However, in case of maxilla, although there are

not obstacles for implant installation such as nerve, patients some-

times complained of facial pain and paraesthesia after surgery.

Objectives:

In this research, we analysed data and observed

progress about facial pain after implant installation on maxilla.

Methods:

This study includes 30 patients who came to the hospital

due to facial pain after maxilla implant from 2001 to 2015. Age,

sex, location of implant, symptoms, onset of pain, progression,

and prescribed drugwere scrutinized retrospectively. We classified

specific diagnosis by clinical data.

Findings:

The average age was 57 years (range, 40–70 years).

Nine patients were male, and 21 patients were female. Seven

patients complained right side facial pain and 23 patients com-

plained other side. Five cases occurred after implant installation

of anterior teeth. There were several trigger factors: first surgery

(

n

= 19), second surgery (

n

= 1), prosthesis fabrication (

n

= 4),

infection such as maxillary sinusitis (

n

= 1) and cryptogenic

(

n

= 5). Patients were observed during 536

±

831 days (range,

0–2906 days). Medicine such as anticonvulsant, antidepres-

sant, vitamin B12, non-steroidal anti-inflammatory drug was

prescribed. Eight patients had constant pain and others had parox-

ysmal pain. Fifteen patients were improved their symptom during

follow up periods.

Conclusion:

We diagnosed 21 cases of posttraumatic trigeminal

neuropathy, eight cases of persistent idiopathic facial pain, and one

case of headache attributed to disorder of the paranasal sinus by

International Classification of Headache Disorders criteria. Fix-

ture was removed in 13 patients. Six patients were improved their

symptom after fixture removal.

http://dx.doi.org/10.1016/j.ijom.2017.02.914

Zygomatic implants in traumatic loss of maxilla

J. Painatt

∗

, R. Veeraraghavan, U. Puthalath, P. Subash

Amrita Institute of Medical Sciences, Kochi, Kerala, India

Background:

Maxillary defects that occur after trauma are highly

challenging for the maxillofacial surgeon to reconstruct and

rehabilitate. The aim of rehabilitation is not only to provide a cos-

metically acceptable appearance, but also to restore oral functions.

Zygomatic implants are not only an alternative to complex free or

vascularised bone grafting but are also used when these techniques

have failed. However, implant placement in the zygoma is difficult

due to the variable anatomy following trauma in the maxillofacial

region.

Case Report:

A 29-year-old male has a history of alleged road

traffic accident in 2014 with maxillofacial fractures. He underwent

reconstructive surgery with multiple complex microvascular flaps

for the maxillofacial defect. He presented to our department with a

failed fibula graft on the maxilla. After comprehensive planning, it

was decided to place zygomatic implants for the maxillary defect.

Conclusion:

Due to both the anatomical complexities of the zygo-

matic bone and the implant length, the placement of zygoma

implants still represents a challenge. To minimise the risks of

surgery, three-dimensional reconstruction, preoperative planning,

registration and surgical implant guidance should be used.

http://dx.doi.org/10.1016/j.ijom.2017.02.915